Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sedigheh Hatami Gigloo
Anti Diabetic Effect of CL 316,243 (A Β3-Adrenergic Agonist) by Down Regulation of Tumour Necrosis Factor (TNF-α) Expression
PLoS ONE
Multidisciplinary
Related publications
The Effect of Tumour Necrosis Factor-Α (TNF-α) Muteins on Human Neutrophilsin Vitro
Mediators of Inflammation
Immunology
Cell Biology
Effect of Neonatal Β3-Adrenoceptor Agonist CL 316,243 Treatment on Body Fat Accumulation and Intestinal Alkaline Phosphatase Activity in Rats From Reduced Nests
Folia Histochemica et Cytobiologica
Medicine
Forensic Medicine
Pathology
Histology
Editorial: Anti-Tumour Necrosis Factor Α Antibodies - Can Efficacy Be Regained?
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Tumour Necrosis Factor Α Decreases Glucose-6-Phosphatase Gene Expression by Activation of Nuclear Factor κB
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Role of Β3-Adrenergic Receptors in the Action of a Tumour Lipid Mobilizing Factor
British Journal of Cancer
Cancer Research
Oncology
Recognition of Human Tumor Necrosis Factor Α (TNF-α) by Therapeutic Antibody Fragment
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Anti-Cytokine Strategies Beyond Anti-Tumour Necrosis Factor-Α Therapy: Pathophysiology and Clinical Implications
Digestive Diseases
Medicine
Gastroenterology
Long-Term Follow-Up of Patients With Tuberculosis as a Complication of Tumour Necrosis Factor (TNF)-α Antagonist Therapy: Safe Re-Initiation of TNF-α Blockers After Appropriate Anti-Tuberculous Treatment
Clinical Microbiology and Infection
Medicine
Infectious Diseases
Microbiology
Type D Personality Is Associated With Increased Levels of Tumour Necrosis Factor (TNF)-α and TNF-α Receptors in Chronic Heart Failure
International Journal of Cardiology
Cardiovascular Medicine
Cardiology
